Douglas Smith, PhD, has been promoted from director of engineering to vice president of engineering for CardiacAssist (Pittsburgh, Pennsylvania). Max Klix-Saravia, formerly controller of the company, was promoted to vice president of finance. The former CFO position was vacated by F. Thomas Casey, who retired. Further additions to the sales management team are Jeffrey Donofrio, who was appointed West Coast sales manager, and Nancy Stahlhut, RN, named Midwest sales manager. Donofrio most recently was Western region sales specialist for WorldHeart. Stahlhut previously was district sales manager for Cardiovention. CardiacAssist manufactures products designed to provide cardiologists and cardiac surgeons with solutions for treating failing hearts.
CardioGenesis (Foothill Ranch, California) has named Marvin Slepian, MD, a prominent interventional cardiologist and inventor of medical therapies and devices including a total artificial heart, as chief scientific officer. Slepian is professor of medicine and director of interventional cardiology at the Sarver Heart Center at the University of Arizona and a member of the CardioGenesis board of directors. He is the founder and CEO of SynCardia Systems, developer of the CardioWest Total Artificial Heart. CardioGenesis is a maker of surgical products and accessories used in transmyocardial revascularization and percutaneous myocardial channeling procedures.
Robert Krist has been named CFO of Endologix (Irvine, California), developer of the Powerlink System endoluminal stent graft for the minimally invasive treatment of abdominal aortic aneurysms. Krist, who previously served as CFO at CardioNet, succeeds David Richards.
Stephen Puckett, founder and chairman of MedCath (Charlotte, North Carolina), has resigned from the company's board of directors. John Casey, MedCath's president and CEO, was named to the additional post of chairman. Puckett started MedCath in December 1988 to operate mobile catheterization labs, bringing complex cardiovascular diagnostics testing to rural areas, and served as the company's president and CEO until 2000. Since then, he has been MedCath's non-executive chairman. MedCath develops, owns and operates hospitals with a total of 759 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, Texas and Wisconsin.
Richard Kramp has resigned as president of MedicalCV (Minneapolis), a maker of devices for cardiovascular surgery. Kramp has been responsible for the company's recent development work in atrial fibrillation products.